Observational Study of iv Ibandronate in Women With Postmenopausal Osteoporosis
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This observational study assess the safety of intravenous Ibandronate (Bonviva) intermittent
administration in patients with postmenopausal osteoporosis and the efficacy of IV
Ibandronate (Bonviva treatment through relative lumbar spine and hip bone mineral
densitometry form baseline at year 1)
Details
Lead Sponsor:
Clinic of Endocrinology and Metabolic Disorders, Macedonia
Collaborators:
Clinic for Orthopedic Surgery, Skopje General Hospital, Kumanovo General Hospital, Struga Medical Faculty, Institute for Epidemiology and Biostatistics, Skopje